The Chemours Company (NYSE:CC) Receives Average Recommendation of “Hold” from Analysts

The Chemours Company (NYSE:CC) has earned a consensus rating of “Hold” from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $23.11.

Several brokerages have recently issued reports on CC. Mizuho lowered their price objective on shares of Chemours from $22.00 to $21.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 7th. Barclays dropped their price objective on shares of Chemours from $23.00 to $19.00 and set an “equal weight” rating on the stock in a report on Monday, February 24th. Royal Bank of Canada reiterated an “outperform” rating and issued a $25.00 target price on shares of Chemours in a research note on Thursday, December 12th. The Goldman Sachs Group lowered their price target on Chemours from $24.00 to $21.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 7th. Finally, BMO Capital Markets reduced their price objective on Chemours from $34.00 to $27.00 and set an “outperform” rating for the company in a research report on Wednesday, February 19th.

Institutional Investors Weigh In On Chemours

Several institutional investors and hedge funds have recently made changes to their positions in CC. Corient Private Wealth LLC boosted its position in Chemours by 4.7% in the fourth quarter. Corient Private Wealth LLC now owns 13,428 shares of the specialty chemicals company’s stock valued at $227,000 after buying an additional 604 shares in the last quarter. KBC Group NV raised its stake in shares of Chemours by 19.5% in the third quarter. KBC Group NV now owns 4,468 shares of the specialty chemicals company’s stock valued at $91,000 after acquiring an additional 728 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Chemours by 99.7% in the 4th quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company’s stock worth $26,000 after acquiring an additional 765 shares in the last quarter. HUB Investment Partners LLC boosted its holdings in shares of Chemours by 1.4% in the 4th quarter. HUB Investment Partners LLC now owns 58,250 shares of the specialty chemicals company’s stock worth $984,000 after acquiring an additional 821 shares in the last quarter. Finally, Itau Unibanco Holding S.A. grew its position in Chemours by 39.3% during the 4th quarter. Itau Unibanco Holding S.A. now owns 3,554 shares of the specialty chemicals company’s stock worth $60,000 after acquiring an additional 1,003 shares during the last quarter. Institutional investors and hedge funds own 76.26% of the company’s stock.

Chemours Stock Down 2.0 %

Chemours stock opened at $13.68 on Friday. The firm has a market cap of $2.04 billion, a price-to-earnings ratio of 24.01 and a beta of 2.00. The firm has a fifty day moving average price of $17.32 and a two-hundred day moving average price of $18.56. Chemours has a fifty-two week low of $13.09 and a fifty-two week high of $29.21. The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92.

Chemours (NYSE:CC) last announced its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.01. The firm had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.37 billion. Chemours had a return on equity of 26.54% and a net margin of 1.51%. As a group, analysts forecast that Chemours will post 2.03 earnings per share for the current year.

Chemours Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 28th will be issued a dividend of $0.25 per share. The ex-dividend date is Friday, February 28th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 7.31%. Chemours’s payout ratio is presently 175.44%.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.